Samsara BioCapital
General contacts
Investor type
VC
Founded
2016
AUM
$1 600 M
Location
Palo Alto, California, United States
Investor profile last updated: 20 April, 2025
Profile
At Samsara BioCapital, we partner with scientists and entrepreneurs to translate cutting-edge science into transformative medicines for patients. We feel incredibly fortunate to invest during a prolific time for biotech and to partner with inspiring companies developing groundbreaking therapies. Our culture is centered on a shared vision: making a significant impact on patients' lives by supporting the development of innovative new treatments.
Industry
Samsara BioCapital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Samsara BioCapital
|
Venture Capital (VC)
|
Biotechnology
Digital
Healthcare Services
Pharmaceuticals
MedTech
Life Sciences
|
Pre-seed
Seed
Series A
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$310 M
|
March 2017
|
Contacts
Name
Title
Email
Social Networks
Investment-team contacts for Samsara BioCapital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
FAQs about Samsara BioCapital
Is Samsara BioCapital a venture capital or private equity firm?
Samsara BioCapital is a venture capital firm. It backs companies at Seed and Series A, writing tickets of $1-5 m.
Where is Samsara BioCapital located?
Samsara BioCapital is located in Palo Alto, California, United States.
When was Samsara BioCapital founded?
Samsara BioCapital was founded in 2016.
What sectors and industries does Samsara BioCapital invest in?
Samsara BioCapital invests in companies and startups in Life Sciences, Digital, Biotechnology, Healthcare Services, Transportation, HealthTech, Pharmaceuticals, MedTech.
What is Samsara BioCapital geographical focus of investments?
Samsara BioCapital invests in companies and startups in North America, Europe.
At what stages of companies and startups does Samsara BioCapital typically invest in?
Samsara BioCapital invests in companies and startups at Seed, Series A.
What is the usual amount of Samsara BioCapital investment?
Samsara BioCapital usually invests $1-5 m on average.
What is the amount of assets of under management (AUM) for Samsara BioCapital?
Samsara BioCapital has around $1 600m assets under management.
When was Samsara BioCapital last fund created?
Samsara BioCapital last fund was created/launched in 2017-03-22
Is Samsara BioCapital impact investor?
Yes, Samsara BioCapital is impact investor.
What are the contacts of Samsara BioCapital?
Samsara BioCapital can be reached through its website samsaracap.com, its LinkedIn page and its X account. Its general enquiries address is info@samsaracap.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Samsara BioCapital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Can I access Samsara BioCapital data via API or MCP?
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Samsara BioCapital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
When was the Samsara BioCapital profile last updated?
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 20 April, 2025. Something out of date here? Report it — we re-run that firm within 48h and get back to you.